MTN-017

Links are provided to information about MTN-017. The first Phase II trial of a rectal microbicide, MTN-017 found that a reduced-glycerin formulation of tenofovir gel was safe when used daily and before and after sex. Study participants were just as likely to follow through using an anti-HIV gel with anal sex as they were to using daily oral pre-exposure prophylaxis (PrEP).

External Links: 
Year: 
2016
Organization: 
Microbicide Trials Network
Languages: 
English